Patent · US Active

Engineered chimeric pegylated ADI and methods of use

US10463721B2 · kind B2 · utility

1Cited by

12References

23Claims

0Family size

Assignee

TDW Group · KY

Inventors

Bor-Wen Wu · San Diego, US
Robert Almassy · Vista, US
Wei He · Audubon, US
Richard E. Showalter · Lakeside, US
Jiaojuan He · Shanghai, CN
Yunyun Guo · Shanghai, CN
James A. Thomson · Madison, US

Key dates

Filing date	Mar 18, 2015
Grant date	Nov 5, 2019
Priority date	—
Expiry date	Nov 20, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are chimeric arginine deiminases, including pegylated chimeric arginine deiminases, and related compositions and methods of use thereof, including methods of treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.